Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%
VYZULTATM (latanoprostene bunod ophthalmic solution), 0.024% is now approved. Read prescribing information and complete a quick form for more information.
This website is hosted with CloudFlare, Inc., which reserves the following IP addresses for vyzulta.com: 104.18.2.66, 104.18.3.66. Moreover, DNS used with this website include ns1.markmonitor.com, ns2.markmonitor.com, ns3.markmonitor.com, ns4.markmonitor.com, ns5.markmonitor.com, ns6.markmonitor.com, ns7.markmonitor.com. Subnet identifier ranges from 104.16.0.0 to 104.31.255.255. Classless Inter-Domain Routing (CIDR) is 104.16.0.0/12. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
CloudFlare, Inc.
ns1.markmonitor.com
ns2.markmonitor.com
ns3.markmonitor.com
ns4.markmonitor.com
ns5.markmonitor.com
ns6.markmonitor.com
ns7.markmonitor.com
{{value}}
2016-02-05
2024-02-05
MarkMonitor Inc.
{{value}}
The registrar of vyzulta.com is MarkMonitor Inc. and the name expires on 2024-02-05. According to open source data, you can reach the owner at domainmanager@valeant.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
N/A
N/A
N/A
125.9K
7.1K
765.3K
N/A
N/A
N/A